FFO
NRXS icon

Fortitude Family Office’s Neuraxis NRXS Stock Holding History

Fortitude Family Office’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-697
Closed -$2.15K – 2055
2025
Q3 		$2.15K Buy
+697
New +$1.78K ﹤0.01% 1190

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $142M AUM 161.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fortitude Family Office's NRXS Position: Q4 2025 in Review

Fortitude Family Office sold out of Neuraxis (NRXS) in Q4 2025, closing a stake of 697 shares — an estimated $2.15K sold.

Fortitude Family Office first reported a position in NRXS in Q3 2025 and held it in 1 quarter. The position peaked at $2.15K in Q3 2025. 18 funds tracked by Wall St. Rank hold NRXS as of Q4 2025.

  • Fortitude Family Office reported no remaining Neuraxis position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 697 Neuraxis shares in Q4 2025, an estimated $2.15K.
  • Fortitude Family Office first reported a position in Neuraxis in Q3 2025 and held it in 1 quarter.
  • Fortitude Family Office's Neuraxis position peaked at $2.15K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Neuraxis as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.